Tag: Goldman Sachs

  • Vaping Retailers Cautious on Outlook of Category

    Vaping Retailers Cautious on Outlook of Category

    Credit: Jet City Image

    Goldman Sachs Managing Director Bonnie Herzog highlighted some key concerns and risks identified by retailers in the survey, along with some key positives for the nicotine industry.

    A recent survey shows convenience-store retailers, distributors and others who sell vaping and other tobacco products are cautious on the outlook for the category.

    This finding comes from Goldman Sachs’ second-quarter 2023 Nicotine Nuggets survey, based on feedback from the New York-based company’s retailer and wholesaler contacts representing about 60,000 locations across the United States, according to CSP Daily.

    Overall, 43 percent of respondents are more negative than the previous quarter in their outlook for the total tobacco/nicotine category in the last few months, citing economic constraints on the consumer, pressure on discretionary incomes, regulations, and tobacco list price increases driving consumers to trade down to cheaper products or exit the category.

    Key concerns and risks that survey respondents identified included price elasticity and downtrading, Goldman Sachs Managing Director Bonnie Herzog highlighted in a report on the survey.

    Recent price increases are forcing consumers to buy less, buy cheaper products or exit the category, she said. One respondent said the current pricing environment is not sustainable for the core tobacco consumer, and that pricing is starting to cut into demand above and beyond the industry 3-5 percent volume declines. In July, Altria took its third cigarette list price increase of 2023.

    As manufacture list price increases reduce consumer options for affordable tobacco products, smokeless nicotine and e-cigarettes are benefitting, survey respondents said.

    Respondents also expressed concern about the proliferation of black-market activity in flavored e-cigarettes as the FDA struggles to remove non-compliant products from the market, Herzog said. Continued premarket tobacco product application (PMTA) delays and marketing denial orders from the FDA on flavored products is benefiting the illicit market, respondents said. Significant traffic is moving to disposable flavored e-cigarettes.

    Key positives from the report included growing sales of non-combustible alternatives and cigarettes continuing to drive store traffic, despite volume declines.

    Several retailers pointed out accelerating trends for flavored disposable vapes and alternative oral nicotine pouches and e-cigarettes.

    And while cigarettes are increasing in price, the segment remains an important category and traffic driver for retailers, as cigarettes make up more than a quarter of total inside sales, Herzog said.

  • IQOS Driving Momentum and Opportunity for PMI

    IQOS Driving Momentum and Opportunity for PMI

    Jacek Olczak

    Presenting at the Goldman Sachs Global Staples Forum on May 18, Philip Morris International CEO Jacek Olczak highlighted the next steps in the company’s strategy to becoming a majority smoke-free company in terms of net revenue by 2025.

    Olczak highlighted IQOS’ strong and accelerating topline momentum and potentially lucrative opportunities to expand beyond nicotine into broader lifestyle/wellness markets, such as high-margin botanicals and respiratory drug delivery.

    IQOS added more than 1.5 million users in the first quarter of 2021, according to Olczak—well above its historical average of 1 million new users per quarter. Robust conversions at 70 percent to 80 percent continue to dwarf the average conversion rates of many vapor products, which are in the mid-teens.

    The heat-not-burn device is now available in 66 markets, with a user base of 19.1 million, of which 14 million have stopped smoking and fully converted to IQOS.

    Olczak was particularly excited about the launch, scheduled for the second half of 2021, of PMI’s ILUMA IQOS product, which he believes could drive even higher conversion rates and margins as PMI continues to leverage its fixed cost base on IQOS while streamlining its customer acquisition and retention.

    Olczak also reviewed management’s ongoing efforts to digitalize and simplify business processes, including PMI’s commercialization strategies around IQOS. According to him, these efforts have already yielded $60 million of gross savings in selling, general and administrative expenses toward management’s target of $1 billion in 2021–2023.

    Olczak believes that PMI’s digitalization efforts will not only further reduce the cost of acquiring and retaining new users and ultimately drive more profitable growth but also accelerate conversion and customer acquisition, especially with the eventual global rollout of PMI’s digital customer experience.

    Olczak also touched on PMI’s longer term opportunities beyond heat-not-burn and vaping, including nicotine pouches and next-generation devices.

    Management is also looking into adjacencies, such as broader lifestyle/wellness markets, such as high-margin botanicals (including pure CBD) and respiratory drug delivery. The company aspires to achieve at least $1 billion in incremental net revenue from its beyond nicotine efforts by 2025.

    Olczak expressed optimism about PMI’s competitive advantages in terms of its capabilities around product safety and efficacy and validating/substantiating scientific claims.